When was Aveo Pharmaceutical founded?

Aveo Pharmaceutical was founded in 2015.

Where is Aveo Pharmaceutical located?

Aveo Pharmaceutical is headquartered in Palghar, India. It is registered at PLOT NO C - 13 MIDC TARAPUR PALGHAR, Thane, PALGHAR, Maharashtra, India, 401506.

Which legal entities is Aveo Pharmaceutical associated with?

Aveo Pharmaceutical is associated with MEYONEX PHARMACEUTICALS LIMITED.

How many employees does Aveo Pharmaceutical have?

As of May 31, 2025, Aveo Pharmaceutical has 48 employees, reflecting a 4% year-over-year decline in headcount.

Is Aveo Pharmaceutical a funded company?

Aveo Pharmaceutical is a funded company, having raised a total of $***** in its 1st and only funding round.

How much is Aveo Pharmaceutical worth?

The last known valuation of Aveo Pharmaceutical was $***** as of Oct 18, 2022.

What is the annual revenue of Aveo Pharmaceutical?

Annual revenue of Aveo Pharmaceutical is ₹108Cr as on Mar 31, 2025.

Where does Aveo Pharmaceutical rank among its competitors?

Aveo Pharmaceutical ranks 89th amongst 368 active competitors, of which 39 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Biofortuna, which secured $303K in Feb, 2026.

Who are the top competitors of Aveo Pharmaceutical?

Aveo Pharmaceutical's top competitors include Novartis, Catalent and Biotage. Among them, Biofortuna secured the most recent funding round in February, 2026.

Aveo Pharmaceutical - 2026 Company Profile, Competitors & Financials

Q: Is Aveo Pharmaceutical an acquired company?

Aveo Pharmaceutical got acquired by Lgchem on Oct 18, 2022.

Aveo Pharmaceutical is an acquired company based in Palghar (India), founded in 2015. It operates as a Provider of drug manufacturing, marketing, and other services. , with last known valuation of $*****. The company has 368 active competitors, including 39 funded and 54 that have exited. Its top competitors include companies like Novartis, Catalent and Biotage.

Company Details

Website: aveo.in/cgi-sys/suspendedpage.cgi
Email ID: *****@aveo.in
Phone Number: +91 **********
Registered Address: PLOT NO C - 13 MIDC TARAPUR PALGHAR, Thane, PALGHAR, Maharashtra, India, 401506

Key Metrics

Founded Year

2015

Location

Palghar, India

Stage

Acquired

Last Known Valuation

$***** as on Oct 18, 2022

Ranked

89^th among 368 active competitors

Annual Revenue

₹108Cr as on Mar 31, 2025

Employee Count

48 as on May 31, 2025

Similar Companies

Novartis & 420 more

Exit Details

Acquired by Lgchem (Oct 18, 2022)

View Aveo Pharmaceutical's full profile

Aveo Pharmaceutical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MEYONEX PHARMACEUTICALS LIMITED CIN: U74120MH2015PLC261024 , India, Active	Jan 17, 2015	$12.8M (As on Mar 31, 2025)	44 (As on Oct 01, 2025)

Aveo Pharmaceutical got acquired by Lgchem on Oct 18, 2022 at an acquisition amount of $*****.

Click here to take a look at Aveo Pharmaceutical's acquisition in detail

Aveo Pharmaceutical has not raised any funding rounds yet.

Aveo Pharmaceutical's employee count trend

Aveo Pharmaceutical has 48 employees as of May 25. The total employee count is 4.0% lower than what it was in May 24. Here is Aveo Pharmaceutical's employee count trend over the years:

Employee count trend for Aveo Pharmaceutical

Uncover Aveo Pharmaceutical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aveo Pharmaceutical include Novartis, Catalent and Biotage. Here is the list of Top 10 competitors of Aveo Pharmaceutical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, MT Capital & 9 others	70/100
2nd	Catalent 2007, Somerset (United States), Acquired	Provider of development, manufacturing, and packaging solutions for medicines and supplements	-	Aisling Capital, Genstar Capital & 3 others	68/100
3rd	Biotage 1989, Uppsala (Sweden), Acquired	Organic synthesis, analytical, and peptide chemistry services for drug discovery and development	-	Taaleri, Investor Growth Capital & 4 others	64/100
4th	Surrozen 2016, San Francisco (United States), Public	Pioneering targeted regenerative antibodies to repair tissue and restore organ function	$133M	The Column Group, Horizons Ventures & 13 others	59/100
5th	BioFactura 2004, Frederick (United States), Series B	Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs	$7.8M	Wilson Sonsini Goodrich & Rosati, UVM Health ... & 2 others	56/100
6th	Biofortuna 2008, Birkenhead (United Kingdom), Series A	Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services	$21.6M	Foresight Group, Gov Wales & 12 others	55/100
7th	Acclinate 2020, Birmingham (United States), Series A	Provider of clinical trial services to biopharma sector	$15.5M	Cencora, Alabama Launchpad & 7 others	55/100
8th	AmplifyBio 2021, Hilliard (United States), Deadpooled	Provider of contract research, development, and manufacturing services for biologic drugs	$230M	Hercules Capital, Casdin Capital	53/100
9th	Sunflower Therapeutics 2018, Hingham (United States), Series A	Provider of drug development & research services for multiple therapeutic areas	$5.64M	NIAID, Clear Current Capital & 3 others	52/100
10th	Curia 1991, Albany (United States), Acquired	Provider of drug research & development, testing, and consulting services	-	The Carlyle Group, Signet Healthcare Partners ... & 4 others	52/100
89th	Aveo Pharmaceutical 2015, Palghar (India), Acquired	Provider of drug manufacturing, marketing, and other services	-	-	27/100